Iphytoral 200mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Iphytoral is administered orally and exhibits good bioavailability when taken with food, enhancing its absorption. The typical dosage regimen varies depending on the type and severity of the infection, and treatment duration may extend from several weeks to months to ensure complete eradication of the pathogen. It is essential to monitor liver function periodically during therapy due to the potential risk of hepatotoxicity. Iphytoral should be used with caution in patients with pre-existing liver disease or congestive heart failure. Drug interactions are significant with itraconazole, as it is a potent inhibitor of cytochrome P450 3A4, necessitating careful review of concomitant medications to avoid adverse effects. Patients should adhere strictly to prescribed dosages and consult healthcare providers before discontinuation or if adverse reactions occur.